Antipsoriatic therapy and skin cancer.
D000873:Anthracenes / Q000009:adverse effects*; D000875:Anthralin / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D011565:Psoriasis / Q000188:drug therapy*; D012878:Skin Neoplasms / Q000139:chemically induced*
D000873:Anthracenes; D000875:Anthralin